Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus.
Sophie DesmondeSimone C FrankAshraf CoovadiaDésiré L DahourouTaige HouElaine J AbramsMadeleine Amorissani-FolquetRochelle P WalenskyRenate StrehlauMartina PenazzatoKenneth A FreedbergLouise KuhnValeriane LeroyAndrea L CiaranelloPublished in: Open forum infectious diseases (2019)
NCT01127204.